SCHEMBL333242

SCHEMBL333242

COc1ccc(F)c(-c2noc(CCC(=O)O)n2)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.67
ATM Q13315 1/20 0.67
HTT P42858 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
GAA P10253 1/20 0.58
ALDH1A1 P00352 7/20 0.58
TP53 P04637 2/20 0.58
TSHR P16473 3/20 0.56
HPGD P15428 2/20 0.56
MITF O75030 1/20 0.55
NCOA3 Q9Y6Q9 1/20 0.55
MAPT P10636 5/20 0.55
BAP1 Q92560 1/20 0.55
FFAR1 O14842 3/20 0.53
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
ALOX15 P16050 1/20 0.51
MAPK1 P28482 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
POLB P06746 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6325644 0.87 LMNA (0.68) LMNAATMHTTSMN1; SMN2GAA
SCHEMBL6325724 0.87 LMNA (0.68) LMNAATMHTTSMN1; SMN2GAA
SCHEMBL1567346 0.80 LMNA (1.00) LMNAATMSMN1; SMN2ALDH1A1TP53
SCHEMBL6332414 0.79 ALDH1A1 (0.65) LMNAHTTSMN1; SMN2GAAALDH1A1
SCHEMBL6324681 0.79 FFAR1 (0.75) LMNAATMHTTSMN1; SMN2ALDH1A1
SCHEMBL6328368 0.78 ALDH1A1 (0.67) LMNAATMHTTSMN1; SMN2GAA
SCHEMBL6327249 0.78 LMNA (0.76) LMNAATMHTTALDH1A1TP53
SCHEMBL7944909 0.77 LMNA (0.64) LMNAATMHTTSMN1; SMN2ALDH1A1
SCHEMBL6325809 0.75 TSHR (0.69) LMNAATMSMN1; SMN2ALDH1A1TP53
SCHEMBL30343673 0.74 POLB (0.69) FFAR1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8097594-B2 Macrolides and ketolides having antimicrobial activity WOCKHARDT LTD. (IN) 2012-01-17 US disclosed
US-20090247478-A1 Novel macrolides and ketolides having antimicrobial activity SINDKHEDKAR MILIND DATTATRAYA 2009-10-01 US disclosed
EP-2056844-A2 NOVEL MACROLIDES AND KETOLIDES HAVING ANTIMICROBIAL ACTIVITY Wockhardt Research Centre (IN) 2009-05-13 EP disclosed
WO-2008023248-A2 NOVEL MACROLIDES AND KETOLIDES HAVING ANTIMICROBIAL ACTIVITY WOCKHARDT RESEARCH CENTRE (IN) 2008-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247478-A1 Novel macrolides and ketolides having antimicrobial activity CYP51A1, CASP12, LSS LMNA 2135/4885ATM 4413/4885HTT 2066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.